MLN
$3.25

Enzyme (MLN) Price

$3.25

Enzyme (MLN) Price Today

The live price of Enzyme is 3.25 USD. In the past 24 hours, the trading volume of Enzyme was 1,355,319.55 USD, down by -1.24%. The current price has decreased by -13.11% from its 7-day high of 258.26 USD, and increased by 1.79% from its 7-day low of 3.48 USD. With a circulating supply of 2,976,485.77 Enzyme, the market cap of Enzyme is currently 25,218,326.00 USD, down by 0% in the last 24 hours. Enzyme currently ranks #1145 by market capitalization among cryptocurrencies.

Enzyme (MLN) Market Data

Market Cap
$9.6M
24h Volume
$1.3M
Circulating Supply
2.9M MLN
Maximum Supply
--
Fully Diluted Market Cap
$9.6M
Liquidity Indicator
13.98%
About
Rate
Leaderboard
FAQ

About Enzyme (MLN)

How can I buy Enzyme (MLN)?

Buying Enzyme (MLN) on BingX is simple and secure. Create an account, deposit USDT or another supported asset, and purchase Enzyme (MLN) directly in the Spot Market. The tokens will then appear in your BingX Spot Wallet, ready for trading or transfer at anytime. Discover How to Buy MLN Guide for more information.

What Is Enzyme (MLN) and How Does It Work?


Enzyme (MLN) is a decentralized asset management protocol that lets you create, manage, and invest in on-chain portfolios using smart contracts. Built originally as Melon Protocol, Enzyme removes traditional fund managers and intermediaries, giving users transparent, non-custodial access to professional-grade portfolio management tools directly on the blockchain.

Enzyme works through vaults, which are smart-contract portfolios that hold assets, execute trades, and follow predefined rules. Vault creators can set parameters such as supported assets, trading strategies, and risk controls, while investors can review performance and allocate capital directly on-chain. All actions, trading, rebalancing, and fee collection, are executed automatically and remain fully auditable.

The MLN token powers the Enzyme ecosystem by covering protocol fees and enabling governance. MLN is used to pay network fees that help maintain the protocol and align incentives, while token holders can participate in governance decisions that shape Enzyme’s future upgrades, integrations, and economic parameters.

When Did Enzyme Finance Launch?


Enzyme originally began its journey as Melon Protocol, a decentralized asset-management project conceived in 2016 by Mona El Isa, a former Goldman Sachs vice-president, and mathematician Rito Trinkler under the Swiss company Melonport AG. The project raised funds through an ICO in February 2017, and after years of development, the mainnet officially launched in 2019. In 2019, Melon Protocol was rebranded to Enzyme Finance as governance transitioned from the original company to a decentralized autonomous organization (DAO) run by the Enzyme Council.

Enzyme Roadmap and Key Milestones


- 2016 – Project founded as Melon Protocol by Mona El Isa and Rito Trinkler.

- Feb 2017 – ICO and token distribution for MLN.

- 2019 – Mainnet launch and rebranding to Enzyme Finance.

- 2021 – V2 upgrade with revised smart contract architecture.

- Feb 2022 – V4 Sulu release with expanded features and multi-chain deployment.

- 2023–2025 – Development of V5, institutional integrations, and ecosystem expansion, e.g., tokenized funds, cross-chain tools.

What Is the MLN Token Utility?


The MLN token is the native utility and governance asset of the Enzyme ecosystem. It is primarily used to pay protocol fees generated by on-chain asset management activities, such as vault operations and fund interactions, with a portion of these fees burned over time to align network usage with token economics. MLN also plays a role in decentralized governance, allowing stakeholders to participate in decisions around protocol upgrades, economic parameters, and long-term development through Enzyme’s DAO-led framework.

You can trade MLN tokens on the BingX spot market by depositing or buying MLN on BingX and accessing the MLN/USDT trading pair. BingX provides real-time price charts, flexible order types, and deep liquidity, making it easy to buy or sell MLN as part of your broader crypto portfolio strategy.

What Is Enzyme Finance Tokenomics?


MLN has a fixed maximum supply of 2.66 million tokens, with no ongoing inflation. The token follows a fee-based burn model, where protocol fees generated from Enzyme vault activity are paid in MLN and partially burned, gradually reducing the circulating supply over time. This creates a usage-linked, deflationary pressure tied directly to platform adoption. MLN is also used for governance, enabling token holders to influence protocol upgrades, integrations, and economic parameters through Enzyme’s DAO-led decision-making process.

 

New Cryptocurrencies and Listings

Explore newly-listed crypto assets on BingX and never miss the next opportunity.

Frequently Asked Questions about MLN (Enzyme)

How much is 1 MLN (Enzyme) worth?
What is the price prediction for MLN (Enzyme)?
What is the all-time high price of MLN (Enzyme)?
What is the all-time low price of MLN (Enzyme)?
How many MLN (Enzyme) are there in circulation?
What is the market capitalization of MLN (Enzyme)?
What affects the price of MLN (Enzyme)?
How Does Enzyme Finance Differ From Traditional Asset Management?
What Blockchain Does Enzyme Finance Operate on?
Which Wallets Support MLN Tokens?
Is Enzyme (MLN) a Good Investment?
Disclaimer:
Price analysis and valuation are influenced by multiple factors, and theoretical projections do not guarantee that a token will reach a specific price level. The information provided is for informational purposes only and does not constitute investment advice. Investors should conduct their own research before making any financial decisions.
By accessing and using this platform, you agree to comply with our Terms of Use.
Trading cryptocurrencies and other financial instruments involves risks, including the potential for loss of funds. You should never trade more than you can afford to lose. Please be aware of the risks involved and seek independent financial advice if necessary.
For more detailed information, please refer to our Risk Disclosure Statement.